Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study of Varlilumab (Anti-CD27) and Sunitinib in Patients With Metastatic Clear Cell Renal Cell Carcinoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02386111
Recruitment Status : Terminated (Portfolio re-prioritization)
First Posted : March 11, 2015
Last Update Posted : July 25, 2018
Sponsor:
Information provided by (Responsible Party):
Celldex Therapeutics

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : August 2017
Actual Study Completion Date : November 3, 2017